G

Galapagos NV
D

GLPG

23.920
USD
0.08
(0.31%)
مغلق
حجم التداول
0
الربح لكل سهم
-2
العائد الربحي
-
P/E
-25
حجم السوق
1,576,257,938
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    -3.460
    (-2.00%)
    169.130 USD
    AMGN
    AMGN
    -1.26
    (-0.46%)
    273.59 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    GILD
    GILD
    0.070
    (0.08%)
    93.020 USD
    I
    INCY
    -1.050
    (-1.43%)
    72.420 USD
    MRK
    MRK
    -0.560
    (-0.58%)
    95.670 USD
    REGN
    REGN
    -7.47
    (-1.09%)
    679.85 USD
    R
    RGEN
    -1.170
    (-0.70%)
    166.730 USD
    VRTX
    VRTX
    0.08
    (0.02%)
    428.09 USD
    المزيد
الأخبار
المقالات

العنوان: Galapagos NV

القطاع: Healthcare
الصناعة: Biotechnology
Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing medicines. The company is committed to improving patients' lives world-wide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan. It derives maximum revenue from United States of America.